References
- The World Health Organization. Reducing risks, promoting healthy life. The World Health Report 2002
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–97
- De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European Society of Cardiology Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Constituted by representatives of eight societies and by invited experts. Eur J Cardiovasc Prev Rehabil 2003;10:S1–10
- Grundy SM, Cleeman JI, Merz CN, et al.; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227–39
- Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459–67
- EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 2001;22:554–72
- Schwandt P, Brady AJ. Achieving lipid goals in Europe: how large is the treatment gap? Expert Rev Cardiovasc Ther 2004;2:431–49
- Erhardt L, Hobbs FDR. Public perceptions of cardiovascular risk in five European countries: the REACT survey. Int J Clin Pract 2002;56:638–44
- Nash IS, Mosca L, Blumenthal RS, et al. Contemporary awareness and understanding of cholesterol as a risk factor: results of an American Heart Association national survey. Arch Intern Med 2003;163:1597–600
- Erhardt LR, Hobbs FDR. A global survey of physicians’ perceptions on cholesterol management: the From The Heart study. Int J Clin Pract 2007;61:1078–85
- Jafary FH, Aslam F, Mahmud H, et al. Cardiovascular health knowledge and behavior in patient attendants at four tertiary care hospitals in Pakistan – a cause for concern. BMC Public Health 2005;5:124
- Angus J, Evans S, Lapum J, et al. ‘Sneaky disease’: the body and health knowledge for people at risk for coronary heart disease in Ontario, Canada. Soc Sci Me 2005;60:2117–28
- McCusker ME, Yoon PW, Gwinn M, et al. Family history of heart disease and cardiovascular disease risk-reducing behaviours. Genet Med 2004;6:153–8
- Khattab MS, Abolfotouh MA, Alakija W, et al. Risk factors of coronary heart disease: attitude and behaviour in family practice in Saudi Arabia. East Mediterr Health J 1999;5:35–45
- Lenz TL, Stading JA. Lifestyle modification counseling of patients with dyslipidemias by pharmacists and other health professionals. J Am Pharm Assoc 2005;45:709–13
- Senior V, Marteau TM, Weinman J. Genetic Risk Assessment for FH Trial (GRAFT) Study Group. Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions. Cardiovasc Drugs Ther 2004;18:475–81
- Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 2005;28:595–9
- Yilmaz MB, Pinar M, Naharci I, et al. Being well-informed about statin is associated with continuous adherence and reaching targets. Cardiovasc Drugs Ther 2005;19:437–40
- Benner JS, Tierce JC, Ballantyne CM, et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoeconomics 2004;22(Suppl 3):13–23
- Alaszewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? BMJ 2003;327:728–31
- Hobbs FDR, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002;19:596–604